In another studies, etomoxir treatment reduced invasion rate of breast cancer cells [53] and decreased sphere formation rate and the CD44 expression, a stemness marker, in lung adenocarcinoma sphere cells (H460) [48]. The gene discussed is CD44; the disease is breast cancer.